High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma: Metabolomics and Mendelian Randomization Analyses

Ophthalmology. 2022 Mar;129(3):285-294. doi: 10.1016/j.ophtha.2021.09.013. Epub 2021 Sep 28.

Abstract

Purpose: We hypothesized that the effect of blood lipid-related metabolites on primary open-angle glaucoma (POAG) would differ according to specific lipoprotein particles and lipid sub-fractions. We investigated the associations of blood levels of lipoprotein particles and lipid sub-fractions with POAG.

Design: Cross-sectional study.

Participants: Individuals recruited for the baseline visit of the population-based Singapore Epidemiology of Eye Disease study (n = 8503).

Methods: All participants underwent detailed standardized ocular and systemic examinations. A total of 130 blood lipid-related metabolites were quantified using a nuclear magnetic resonance metabolomics platform. The analyses were conducted in 2 stages. First, we investigated whether and which lipid-related metabolites were directly associated with POAG using regression analyses followed by Bayesian network modeling. Second, we investigated if any causal relationship exists between the identified lipid-related metabolites, if any, and POAG using 2-sample Mendelian randomization (MR) analysis. We performed genome-wide association studies (GWAS) on high-density lipoprotein (HDL) 3 cholesterol (after inverse normal transformation) and used the top variants associated with HLD3 cholesterol as instrumental variables (IVs) in the MR analysis.

Main outcome measure: Primary open-angle glaucoma.

Results: Of the participants, 175 (2.1%) had POAG. First, a logistic regression model showed that total HDL3 cholesterol (negatively) and phospholipids in very large HDL (positively) were associated with POAG. Further analyses using a Bayesian network analysis showed that only total HDL3 cholesterol was directly associated with POAG (odds ratio [OR], 0.72 per 1 standard deviation increase in HDL3 cholesterol; 95% confidence interval [CI], 0.61-0.84), independently of age, gender, intraocular pressure (IOP), body mass index (BMI), education level, systolic blood pressure, axial length, and statin medication. Using 5 IVs identified from the GWAS and with the inverse variance weighted MR method, we found that higher levels of HDL3 cholesterol were associated with a decreased odds of POAG (OR, 0.91; 95% CI, 0.84-0.99, P = 0.021). Other MR methods, including weighted median, mode-based estimator, and contamination mixture methods, derived consistent OR estimates. None of the routine lipids (blood total, HDL, or low-density lipoprotein [LDL] cholesterol) were associated with POAG.

Conclusions: Overall, these results suggest that the relationship between HDL3 cholesterol and POAG might be causal and specific, and that dysregulation of cholesterol transport may play a role in the pathogenesis of POAG.

Keywords: Additive Bayesian network; Genome-wide association study; HDL3 cholesterol; Mendelian randomization; NMR metabolomics; Primary open-angle glaucoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cholesterol, HDL / blood*
  • Cross-Sectional Studies
  • Female
  • Genome-Wide Association Study
  • Glaucoma, Open-Angle / blood*
  • Glaucoma, Open-Angle / diagnosis
  • Gonioscopy
  • Humans
  • Magnetic Resonance Spectroscopy
  • Male
  • Mendelian Randomization Analysis*
  • Metabolomics*
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Slit Lamp Microscopy
  • Tonometry, Ocular

Substances

  • Cholesterol, HDL